Filing Details

Accession Number:
0000950138-19-000139
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-13 18:10:54
Reporting Period:
2019-03-11
Accepted Time:
2019-03-13 18:10:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1739104 Elanco Animal Health Inc ELAN Pharmaceutical Preparations (2834) 825497352
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1752446 Alan David Urbanek C/O Elanco Animal Health Incorporated
2500 Innovation Way
Greenfield IN 46140
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-11 2,021 $0.00 14,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. On March 11, 2019, Eli Lilly and Company ("Lilly") announced the completion of its offer to exchange shares of Lilly common stock for all of the common stock of the Issuer owned by Lilly (the "Exchange Offer"). The Reporting Person tendered 3,294 shares of Lilly common stock in the Exchange Offer, which shares were subject to a proration factor of 13.5970839%. As a result, the Reporting Person received 2,021 shares of Issuer common stock in exchange for 448 shares of Lilly common stock accepted in the Exchange Offer, based on an exchange ratio of 4.5121 shares of Issuer common stock for each share of Lilly common stock accepted.